- Assessing the risk of developing congenital malformations in a new generation, associated with the impact of risk factors (chemical, physical, etc.) on adults of fertile age,
- Assessing the prevalence and ratio of various types of chromosomal abnormalities in fetuses, newborns and adults with impaired reproductive function,
- Detecting and assessing chromosomal abnormalities, inducing early developmental disorders and pregnancy pathologies (spontaneous abortion, intrauterine fetal death), in individuals exposed to risk factors,
- Detecting congenital malformations or micro-abnormalities in children and adolescents, which are manifested during the pre- and post-pubertal period (mental retardation, delayed or precocious puberty puberty), under exposure to chemical risk factors,
- Determining the frequency and range of chromosomal disorders and mutations, caused by medications, cosmetics, food and food additives,
- Collecting, storing and processing data on the incidence and prevalence of chromosomal disorders and mutations, associated with risk factors; substantiating markers of exposure and cytogenetic markers of effect.